- Home
- INM vs CHSCL Comparison
INM vs CHSCL Comparison
Compare INM & CHSCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- CHSCL
- Stock Information
- Founded
- INM 1981
- CHSCL N/A
- Country
- INM Canada
- CHSCL United States
- Employees
- INM N/A
- CHSCL N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- CHSCL Farming/Seeds/Milling
- Sector
- INM Health Care
- CHSCL Industrials
- Exchange
- INM Nasdaq
- CHSCL Nasdaq
- Market Cap
- INM 3.2M
- CHSCL N/A
- IPO Year
- INM N/A
- CHSCL N/A
- Fundamental
- Price
- INM $2.30
- CHSCL $25.56
- Analyst Decision
- INM
- CHSCL
- Analyst Count
- INM 0
- CHSCL 0
- Target Price
- INM N/A
- CHSCL N/A
- AVG Volume (30 Days)
- INM 46.6K
- CHSCL N/A
- Earning Date
- INM 05-13-2025
- CHSCL N/A
- Dividend Yield
- INM N/A
- CHSCL N/A
- EPS Growth
- INM N/A
- CHSCL N/A
- EPS
- INM N/A
- CHSCL N/A
- Revenue
- INM $4,832,013.00
- CHSCL N/A
- Revenue This Year
- INM N/A
- CHSCL N/A
- Revenue Next Year
- INM N/A
- CHSCL N/A
- P/E Ratio
- INM N/A
- CHSCL N/A
- Revenue Growth
- INM N/A
- CHSCL N/A
- 52 Week Low
- INM $1.72
- CHSCL N/A
- 52 Week High
- INM $15.70
- CHSCL N/A
- Technical
- Relative Strength Index (RSI)
- INM 34.09
- CHSCL 47.41
- Support Level
- INM $2.70
- CHSCL $25.50
- Resistance Level
- INM $3.20
- CHSCL $25.76
- Average True Range (ATR)
- INM 0.23
- CHSCL 0.13
- MACD
- INM -0.05
- CHSCL 0.02
- Stochastic Oscillator
- INM 5.26
- CHSCL 52.70
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About CHSCL CHS Inc Class B Cumulative Redeemable Preferred Stock Series 4
CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).